openPR Logo
Press release

Bladder Cancer Market 2018; Development of the New Molecules and Therapies | Worldwide Players Is Boosting At A CAGR Of 12.5% By 2023 – Says MRFR

06-12-2018 08:40 AM CET | Business, Economy, Finances, Banking & Insurance

Press release from: Market Research Future

Bladder Cancer Market

Bladder Cancer Market

Bladder Cancer Market Report include on MarketReseacrhFuture.com with exhaustive Study. The report aims to provide an overview of Bladder Cancer Market Report. The report provides key statistics on the market status. Global Forecast till 2023.

Global Bladder Cancer Market - Overview

The global market for bladder cancer is growing at a steady pace. This can be attributed to increasing prevalence of bladder cancer. It is reported that the exact cause of the bladder cancer is not clear, however, the medical condition is estimated to be aaocaited with certain factors which are inclusive mutations in the genetic composition of the patients, continuous exposure to harmful radiations, and adoption of unhealthy lifestyle. Such conditions are responsible for increasing the reported cases of bladder cancer across the globe. Moreover, factors such as increasing government support alongwith the growing investment in the research and development procees boosts the market growth. Adfditionally, rising awareness regarding the medical condition among the masses also contributs to the market growth. However, there factors such as  high cost of the treatment in terms of expensive drugs, and related side effects are estimated to restarin the market tgrowth during the projected period.

Avail Premium Sample copy @ https://www.marketresearchfuture.com/sample_request/1899 .

Prominent Players:

The global market consist of players such as, Oncogenex (US), Astellas (Japan), Eli Lilly and Company (US), AstraZeneca (UK), F. Hoffmann-La Roche (Switzerland), GlaxoSmithKline (UK), Accord Healthcare, Inc.(India), Pfizer (US), Novartis AG (Switzerland) Bristol-Myers Squibb company (US) and others. These are some of the major market players at the forefront of competition in the global bladder cancer market.

Global Bladder Cancer Market - Competitive Analysis

The market for bladder cancer is well established market with number of companies operating in this market.

Bladder Cancer Market is expected to grow in the presence of increasing demands for better rtherapeutics. Currently, the market is witnissing an unavailability of absolute treatment. This can be seen as an for the market players to expand their market. The players, present in the global  bladder cancer market are focusing on the development of new products. Such novel  products are being designed with views of cost effectiveness and minimum side effects. Therefore, many companies in the market are involved in the development of specific types of molecules, and novel therapies have adopted the strategies of the acquisitions, product launches in order to strive in the competitive market. Additionally, competition amongst new entrants is expected to increase the growth for bladder cancer market over the forecasted period.

In October 2017, Astellas and Seattle Genetics initiated pivotal trial of Enfortumab Vedotin for patients with locally advanced or metastatic urothelial cancer.

In May 2017, AstraZeneca plc received U.S. FDA accelerated approval for the drug Imfinzi (durvalumab). This drug is intended to be used for previously treated patients with advanced bladder cancer.

In February 2017, Bristol-Myers Squibb received the FDA approval for Opdivo (nivolumab) in previously treated locally advanced or metastatic urothelial carcinoma, a type of bladder cancer.

In April 2017, FDA granted Roche’s atezolizumab, an accelerated approval as an initial treatment procedure for treating patients with advanced bladder cancer. It is the only immunotherapy paradigm approved for the treatment of advanced bladder cancer.  

Avail Stunning Discount @ https://www.marketresearchfuture.com/check-discount/1899 .

In May 2017, Eli Lily & company announced results of their drug Cyramza’s phase III clinical trial for Bladder cancer. According to company reports, around 531 patients with urothelial carcinoma were treated in the trial, with a statistically significant improvement in progression-free survival. With this, Company received huge boost for the development of this drug in the treatment of bladder cancer.

In May 2017, FDA granted BAVENCIO (avelumab) approval for a common type of advanced bladder cancer.

Global Bladder Cancer Market - Regional Analysis

On the basis of the geography, the global bladder cancer market is segmented into the four major regions, namely the Americas, Europe, Asia Pacific, and the Middle East & Africa.

The Americas holds the largest share in the global bladder cancer market.  Presence of huge patient population suffering from bladder cancer is a major reason behind the same. As per the American Cancer Society, approximately 79,030 new cases of bladder cancer were reported  in 2017. Moreover, it was estimated that the disease caused about 16,870 deaths withihn the U.S. Additionally, factors includfing changing lifestyle, rising government support, incrteasing role of cancer care organisations for incraesing the awareness s also impacts a positive  growth in the global bladder cancer market.

Europe accounts for the second largest market share for the bladder cancer, which is followed by Asia Pacific. Asia Pacific is the fastest growing market owing to the huge population base, increasing prevalence of bladder cancer, rapidly developing economies and presence of huge opportunity for the growth of the market. The Middle East & Africa has the least market share due to the unavailability of the required healthcare infrastructure, lack of awareness among people, and affordability issues due to presence of the poor economies in Africa region.

Ask any Queries to Experts about Niche Segments, Requires Regional Data and Top Players @ https://www.marketresearchfuture.com/enquiry/1899 .

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact

Market Research Future

Office No. 528, Amanora Chambers

Magarpatta Road, Hadapsar,

Pune – 411028

Maharashtra, India

+1 646 845 9312

Email: sales@marketresearchfuture.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Bladder Cancer Market 2018; Development of the New Molecules and Therapies | Worldwide Players Is Boosting At A CAGR Of 12.5% By 2023 – Says MRFR here

News-ID: 1078311 • Views:

More Releases from Market Research Future

Hydrofluoric Acid Market (CAGR) of 4%, Innovation Imperative Future Proofing Your Business with Market Size
Hydrofluoric Acid Market (CAGR) of 4%, Innovation Imperative Future Proofing You …
Hydrofluoric acid (HF) is a crucial chemical compound with a wide range of applications across various industries. Despite its hazardous nature, it plays an essential role in manufacturing processes, especially in the production of fluorine compounds. The global hydrofluoric acid market has been witnessing steady growth, driven by demand from end-user industries such as oil refining, pharmaceuticals, and electronics. The Hydrodesulfurization Catalysts Market is projected to register a CAGR of over
Palm Methyl Ester Derivative Market Size Projected to Grow at 5.92% CAGR, Reaching USD 2.4 billion by 2030
Palm Methyl Ester Derivative Market Size Projected to Grow at 5.92% CAGR, Reachi …
In recent years, the global market for palm methyl ester derivatives has witnessed significant growth, driven by various factors including environmental concerns, technological advancements, and the increasing demand for sustainable alternatives in various industries. Palm methyl ester derivatives, derived from palm oil, have emerged as versatile ingredients with applications spanning across sectors such as cosmetics, pharmaceuticals, lubricants, and more. The Palm Methyl Ester Derivative Market Size was valued at USD 1.5
Asia-Pacific Ceramic Tiles Market to Register Highest CAGR Growth of 7.50% by 2032: Analysis by Segmentation, Competitors Analysis
Asia-Pacific Ceramic Tiles Market to Register Highest CAGR Growth of 7.50% by 20 …
The Asia-Pacific ceramic tiles market has been witnessing robust growth, driven by various factors such as increasing investments in residential and commercial construction, renovation activities, and the growing preference for aesthetically pleasing and durable flooring solutions. Countries like China, India, Japan, and South Korea have been leading the market growth, supported by strong manufacturing capabilities, technological advancements, and evolving consumer preferences. Asia-Pacific Ceramic Tiles Market Size was valued at USD 141.2
APAC Wallpaper Market to Register Highest CAGR Growth of 8% by 2032: Analysis by Segmentation, Competitors Analysis
APAC Wallpaper Market to Register Highest CAGR Growth of 8% by 2032: Analysis by …
The APAC wallpaper market has witnessed significant growth in recent years, driven by factors such as rising disposable incomes, expanding construction activities, and growing awareness regarding interior decor. Countries like China, India, Japan, South Korea, and Australia have emerged as key contributors to the region's wallpaper market. Additionally, the increasing adoption of innovative wallpaper designs and patterns is fueling market growth further. APAC Wallpaper Market Size was valued at USD 0.55

All 5 Releases


More Releases for Bladder

Overactive Bladder (OAB) - Drug Pipeline Landscape, 2022
Overactive bladder (OAB) is a condition in which the bladder muscle contracts too often and causes urinary frequency, urgency, and incontinence. It affects both men and women, but is more common in women. The causes of overactive bladder include neurological disorders, such as stroke, multiple sclerosis and eak pelvic muscles, diabetes, urinary tract infections, excess consumption of caffeine or alcohol, declining cognitive function due to aging, difficulty walking. The most common symptoms
Bladder Cancer Therapeutics Market : How the Bladder Cancer Therapeutics Market …
As per stats released by the World Cancer Research Fund International, around 430,000 new cases of bladder cancer were diagnosed in 2012, with bladder cancer being the ninth-most common cancer. The bladder holds urine before it leaves the body during urination. The disease in which cancerous cells form in the tissues of the bladder is known as bladder cancer. Download Free PDF Brochure Of This Research Report @ https://www.coherentmarketinsights.com/insight/request-pdf/239 There
Global Bladder Scanners Sales Market Report 2018
This report studies the global Bladder Scanners market status and forecast, categorizes the global Bladder Scanners market size (value & volume) by key players, type, application, and region. This report focuses on the top players in North America, Europe, China, Japan, Southeast Asia India and Other regions (Middle East & Africa, Central & South America). A bladder scanner is a medical device that utilizes ultrasound to noninvasively measure the amount of
Bladder Cance rMarket entry and expansion strategies
MarketResearchReports.Biz adds “Global Bladder Cancer Market Share, Size, Trends and Forecast Market Research Report” reports to its database. This report provides a strategic analysis of the Bladder Cancer and the growth estimates for the forecasted period. Bladder cancer is a rapidly evolving field in which new developments are constantly influencing the market landscape. The Dynamic Market Forecast is designed to help clients stay abreast of the latest news in the bladder
Bladder Cancer Pharmaceutical and Healthcare Analysis Information
Summary Bladder cancer occurs in tissues of the urinary bladder. Symptoms include blood or blood clots in the urine, frequent urination, lower back pain on one side of the body and burning during urination. Risk factors for bladder cancer include smoking, exposure to substances such as rubber, certain dyes and textiles, paint, and hairdressing supplies, diet rich in fried meats and fat, old age, sex and color, certain parasitic infections. Treatment
Bladder Scanners Market Research Report 2011-2023
Browse full table of contents and data tables at : https://www.reportsandmarkets.com/reports/global-bladder-scanners-market-research-report-2011-2023-1476292 Summary A bladder scanner is a medical device that utilizes ultrasound to noninvasively measure the amount of urine in the bladder or to determine how much urine remains in the bladder after urination as a way to measure residual levels. Request a sample copy at : https://www.reportsandmarkets.com/sample-request/global-bladder-scanners-market-research-report-2011-2023-1476292 The type of scanner is a niche ultrasound system that provides fast